FDA Expands ASCENIV Pediatric Use - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA Expands ASCENIV Pediatric Use

Label change follows completion of required pediatric evaluation and updates prior age restrictions for treatment eligibility.

  • By

  • Kathryn Wighton

  • May 4, 2026

  • 2 min

Share

Original Source(s)

FDA Expands ASCENIV Pediatric Use

  • by Kathryn Wighton

  • May 4, 2026

Related Content

FDA approves XFG-adapted COVID-19 vaccine

The 2026 to 2027 formulation aligns with FDA guidance on the preferred composition for COVID-19 vaccines beginning this fall.

Further Reflections on Metabolically Healthy Obesity in Children

Do antihistamines help atopic dermatitis?

First-generation H1 antihistamines likely increase cognitive impairment, with cognitive effects differing among second-generation antihistamines.